These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4340548)

  • 1. [Immunology of brain tumors: the glial carcino-fetal antigen].
    Trouillas P
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):819-28. PubMed ID: 4340548
    [No Abstract]   [Full Text] [Related]  

  • 2. Surface antigens of human glioma cells shared with normal adult and fetal brain.
    Wikstrand CJ; Bigner DD
    Cancer Res; 1979 Aug; 39(8):3235-43. PubMed ID: 88260
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcino-fetal antigen in glial tumours.
    Trouillas P
    Lancet; 1971 Sep; 2(7723):552. PubMed ID: 4105703
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological study of cerebral tumors in vitro].
    Febvre H; Maunoury R; Constans JP
    Neurochirurgie; 1971; 17(3):203-7. PubMed ID: 4330107
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Immunological investigations on human brain tumor patients.
    Mahaley MS
    Proc Natl Cancer Conf; 1972; 7():811-5. PubMed ID: 4358071
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antigen of an RNA oncogenic virus in human glioma. Its relationship with carcino-embryonic antigens].
    Trouillas P
    Nouv Presse Med; 1972 Aug; 1(30):1979-82. PubMed ID: 4627867
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies on mouse fetal antigen cross-reactive with Rauscher leukemia.
    Ishimoto A; Suzuki Y; Yoshida T; Ito Y
    Cancer Res; 1974 Sep; 34(9):2338-43. PubMed ID: 4846102
    [No Abstract]   [Full Text] [Related]  

  • 8. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of immunologic studies in malignant tumors of the human brain].
    Romodanov AP; Lisianyĭ NI; Prikhodchenko IA
    Zh Vopr Neirokhir Im N N Burdenko; 1983; (3):56-9. PubMed ID: 6310917
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunogenic properties of human brain glioma antigens evaluated with rabbit sera by means of a complement fixation test].
    Rybarska I
    Neuropatol Pol; 1975; 13(2):183-94. PubMed ID: 167322
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibodies to glial fibrillary antigen as potential carriers of drugs for glial tumors].
    Obukhov SK; Kalashnikova VV; Khalanskiĭ AS
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (2):30-2. PubMed ID: 2787569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
    Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD
    Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity and tumors of the nervous system.
    Brooks WH; Netsky MG; Levine JE
    Surg Neurol; 1975 Apr; 3(4):184-6. PubMed ID: 1145415
    [No Abstract]   [Full Text] [Related]  

  • 14. Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence.
    Solheid C; Lauro G; Palladini G
    J Neurol Sci; 1976 Nov; 30(1):55-64. PubMed ID: 789826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunology and immunotherapy of cerebral tumors. Current status].
    Trouillas P
    Rev Neurol (Paris); 1973 Jan; 128(1):23-38. PubMed ID: 4367367
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on cellular immunity of brain tumors; glial carcinofetal antigens and serum blocking factors in gliomas (author's transl)].
    Oda Y
    Nihon Geka Hokan; 1974 Mar; 43(2):111-23. PubMed ID: 4472615
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunochemical study of alpha-1 organospecific antigen in different sections of the brain and CNS tumors].
    Obukhov SK; Kasumova SIu; Kalashnikov VV
    Vopr Onkol; 1981; 27(2):61-4. PubMed ID: 6163253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro demonstration of cell-mediated immunity to human brain tumors.
    Levy NL; Mahaley MS; Day ED
    Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410
    [No Abstract]   [Full Text] [Related]  

  • 19. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
    Levy NL
    J Immunol; 1978 Sep; 121(3):903-15. PubMed ID: 211167
    [No Abstract]   [Full Text] [Related]  

  • 20. [Autoantibodies in glioblastoma multiforme (author's transl)].
    Roda JE; Heredero JJ; Villarejo FJ; Roda JM
    Arch Neurobiol (Madr); 1980; 43(6):377-90. PubMed ID: 6258534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.